Innovation Stage
Expo Hall, #4225

Check out ACC's Innovation Stage — a unique theater that provides an opportunity to enjoy a 30-minute focused discussion in a relaxed setting.

Quick Links: Saturday, April 6Sunday, April 7Monday, April 8

Saturday, April 6

9:45 – 10:15 a.m.

4201. The Heart of Collaboration: Best Practices For Monitoring Valve Performance
Sponsored by Medtronic

Join us for a special event designed for Advanced Practice Providers (APPs) and heart teams. Discuss valve performance and real-world implications from a comprehensive cardiac team of experts.

Michael Querijero, PA

Deepak Talreja, MD
Matthew Summers, MD
Sarah Kennedy, NP

10:45 – 11:15 a.m.

4202. Expert Perspectives on Stroke Risk Reduction in NVAF, With a Focus on High-Risk Patient Populations
Sponsored by Johnson & Johnson

Distinguished faculty will provide expert perspectives on stroke risk reduction in NVAF. In addition, this discussion covers high-risk patient populations, including those with obesity, older age, renal impairment, and prior stroke.

12:30 – 1 p.m.

4203. The Hidden Risk Factor: The Underappreciated Role of Lp(a) in ASCVD
Sponsored by Amgen

Come listen as Dr. Kaul and Dr. Desai discuss why it is important to recognize elevated levels of lipoprotein(a) as an emerging cardiovascular risk factor patients with atherosclerotic cardiovascular disease.

Sanjay Kaul, MD
Nihar Desai, MD

1:30 – 2 p.m.

4204. Implementing Treprostinil Induction Strategies in Pulmonary Arterial Hypertension
Sponsored by United Therapeutics

Explore the potential of treprostinil induction therapy with lessons from the EXPEDITE study.

Ronald J. Oudiz, MD, FACC

3:30 p.m. – 4:00 p.m.

4205. Breakthrough Innovation: Expert Consensus on Structural Heart Imaging With Intracardiac Echocardiography Led by the Global 4D ICE Imaging Consortium
Sponsored by Siemens Medical Solutions USA, Inc

The Global 4D ICE Imaging Consortium comprises a panel of experts in the field of structural heart imaging, specifically using intracardiac echocardiography (ICE). The Consortium has developed an expert consensus on:
  • Structural heart interventions
  • Procedural guidance with ICE
  • Assessment of structural heart disease with ICE
  • Education and training in ICE

Sunday, April 7

9:15 – 9:45 a.m.

4206. Expert Perspectives on the Treatment of DVT/PE and Reduction in the Risk of Recurrent DVT/PE, With a Focus on High-Risk Patient Populations
Sponsored by Johnson & Johnson

Distinguished faculty will provide expert perspectives on the treatment of deep vein thrombosis (DVT) and/or pulmonary embolism (PE) and reduction in the risk of recurrent DVT and/or PE. In addition, this discussion includes high-risk patient populations and how obesity, cancer, fragility, and renal impairment increase risks of recurrent DVT/PE.

Sonya S. Noor, MD, FACS
Medical Director, Endovascular Services
Buffalo General Medical Center & Gates Vascular Institute
Vascular Surgeon
Buffalo Endovascular and Vascular Surgical Associates (BEVSA)
Buffalo, New York

11 – 11:30 a.m.

4207. Beyond the Beat: Patient-Centric Workflows, Powered by AI
Sponsored by

Join us at an intersection where innovation meets impact, sponsored by Physicians will share their perspectives on how AI-powered workflow transformations are elevating hypertrophic cardiomyopathy patient outcomes today, and their broader potential in cardiology tomorrow.

Milind Desai, MD, MBA

1:30 – 2 p.m.

4208. Expert Discussion on the Head-to-Head SMART Trial: Implications For TAVR and Women's Health
Sponsored by Medtronic

Join cardiology experts as they discuss the first head-to-head SMART trial. Discover its impact on TAVR decision-making and its role in advancing treatment for aortic stenosis in women – an underserved patient population.

Martha Gulati, MD, FACC
Howard C. Herrmann, MD, FACC
Roxana Mehran, MD, FACC
Didier Tchétché, MD

3:45 – 4:15 p.m.

4209. Disrupting the Status Quo: Aldosterone Dysregulation in the Pathogenesis of Hypertension
Sponsored by AstraZeneca

Mounting evidence points to a pivotal role for aldosterone dysregulation in the pathogenesis of hypertension. Importantly, the pathogenic effects of aldosterone extend beyond hypertension, contributing to HF, CVD and CKD through a complex series of mechanisms. This suggests a significant shift is needed in our understanding of the pathology of aldosterone dysregulation.

George L. Bakris, MD

Monday, April 8

9:45 – 10:15 a.m.

4210. Revolutionizing Cardiac Imaging: Artificial Intelligence and Handheld Ultrasound
Sponsored by GE Healthcare

Dr. Strom will discuss how utilizing Vscan Air handheld ultrasound in the cardiac care pathway can help detect signs of disease earlier, and how artificial intelligence can enable reliable and consistent examinations.

Jordan Strom, MD, MSc, FACC, FASE

12:15 – 12:45 p.m.

4211. Title to be Announced
Sponsor to be announced

Information current as of Feb. 22, 2024.

Innovation Stage presentations are not part of ACC.24, as planned by its Program Committee, and do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

American College of Cardiology

© 2023 American College of Cardiology Foundation. Visit

Terms and Conditions Registered User Agreement Advertising and Sponsorship Policy Privacy Policy Cookie Policy Contact Us